These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 36260)

  • 1. Improvement in arterial oxygenation by saralasin infusion in man.
    Mookherjee S; Obeid AI; Ashutosh K; Warner RA; Smulyan H
    Chest; 1979 Apr; 75(4):492-4. PubMed ID: 36260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial oxygenation and pulmonary function with Saralasin in chronic lung disease.
    Mookherjee S; Ashutosh K; Smulyan H; Vardan S; Warner R
    Chest; 1983 Jun; 83(6):842-7. PubMed ID: 6406162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
    Mookherjee S; Obeid A; Warner R; Anderson G; Eich R; Smulyan H
    Am J Cardiol; 1978 Dec; 42(6):987-92. PubMed ID: 727149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic correlates of saralasin-induced arterial pressure changes.
    de Carvalho JG; Dunn FG; Kem DC; Chrysant SG; Froholich ED
    Circulation; 1978 Feb; 57(2):373-8. PubMed ID: 618629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
    Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I
    JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency].
    Tuma J; Beckerhoff R; Záruba K; Furrer J; Vetter W
    Schweiz Med Wochenschr; 1977 May; 107(20):704-9. PubMed ID: 867013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
    Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II blockade in congestive heart failure.
    Turini GA; Brunner HR; Ferguson RK; Rivier JL; Gavras H
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):166-76. PubMed ID: 686905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.
    Davidson D; Stalcup SA
    J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate].
    Mimran A; Deschodt G; Shaldon S; Barjon P; Mion C
    Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():19-24. PubMed ID: 101176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
    Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ
    J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs.
    Rose CE; Godine RL; Rose KY; Anderson RJ; Carey RM
    J Clin Invest; 1984 Aug; 74(2):321-31. PubMed ID: 6547729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous phentolamine on hemodynamics and resting pulmonary gas exchange in man.
    Gould L; Reddy CV; Becker WH; Macklin EE
    Angiology; 1980 Feb; 31(2):120-5. PubMed ID: 7362073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of saralasin upon plasma catecholamines in hypertensive patients.
    Vlachakis ND; Ribeiro AB; Krakoff LR
    Am Heart J; 1978 Jan; 95(1):78-80. PubMed ID: 619593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebound hypertensive after sodium nitroprusside prevented by saralasin in rats.
    Delaney TJ; Miller ED
    Anesthesiology; 1980 Feb; 52(2):154-6. PubMed ID: 7352670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
    Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.